UMOD rs12917707 variation influences kidney function and CKD risk.

The UMOD rs12917707 variant is one of the most well-validated genetic markers for kidney health, directly influencing both estimated glomerular filtration rate (eGFR) and the long-term risk of chronic kidney disease (CKD).

Clinical and effectiveness evidence

Large-scale population studies, including data from the UK Biobank and the CKDGen consortium (hundreds of thousands of participants), consistently identify rs12917707 as a top locus associated with kidney function.

• eGFR and CKD Risk: Each risk allele is associated with a 0.5% to 1.5% reduction in eGFR. While the individual effect size is modest, it is highly significant at the population level due to the variant's high frequency.
• End-Stage Renal Disease (ESRD): Meta-analyses show that specific alleles confer protection against severe kidney failure. For example, the minor allele (often T) is associated with a reduced risk of ESRD, with an odds ratio (OR) of 0.91 (95% CI: 0.88–0.94), indicating a roughly 9% reduction in risk.

Mechanistic explanations

The UMOD gene encodes uromodulin (Tamm-Horsfall protein), the most abundant protein in normal urine, which is produced exclusively in the thick ascending limb (TAL) of the loop of Henle.

• Gene Expression: The rs12917707 variant acts as a regulatory element that modulates UMOD expression. The common G allele is linked to higher uromodulin secretion in a gene-dosage manner.
• Pathophysiology: While uromodulin provides local protection against infections and stones in the urinary tract, chronically elevated levels are causally linked to kidney damage. Mendelian randomization studies confirm this causality, showing that higher genetically predicted uromodulin levels increase the odds of CKD (OR 1.30 per standard deviation increase). This is likely due to the metabolic stress higher protein production places on TAL cells, leading to interstitial fibrosis and tubular atrophy over time.

Bottom line

The UMOD rs12917707 variation is a major genetic determinant of kidney function. It operates by controlling uromodulin levels, where higher genetically driven protein production increases the risk of developing chronic kidney disease and accelerating eGFR decline.